The TMRW Vault replaces traditional, manual cryostorage methods with a centralized digital ecosystem. By integrating RFID-enabled tracking through CryoBeacons and the proprietary ivfOS software, the system provides real-time inventory management and a secure digital chain-of-custody for oocytes, embryos, and sperm. The technology is designed to mitigate human error, a persistent challenge as clinics handle increasing volumes of frozen reproductive samples.
In section Releases
Reprotech’s TMRW Vault Gains EU Regulatory Approval
The TMRW Vault, a specialized cryogenic storage system for reproductive tissues, has secured CE marking as a Class IIa medical device. This regulatory milestone under the European Union’s Medical Device Regulation (MDR) paves the way for Reprotech to expand its automated specimen management technology across European fertility clinics.
Beyond digital oversight, the hardware improves physical efficiency. A single TMRW Vault tank occupies roughly one-third of the footprint of ten conventional dewars while maintaining high-capacity storage. The system also features TMRW Overwatch, which conducts thousands of daily diagnostic checks to ensure specimen integrity. This certification follows the April 2026 merger between Reprotech and TMRW Life Sciences, which combined the former’s biorepository network with advanced digital monitoring capabilities. With this approval, the organization aims to standardize specimen traceability and safety protocols across international markets.
Comments (0)
No comments yet. Be the first!